Skip to content
Hair Pipeline
← Recruiting trials
NCT07107841Completed

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for the Treatment of Androgenic Alopecia (Single Site)

In the register

This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.

What the registry records

Status
Completed
Declared phase
Not applicable (NA in the registry)
Sponsor
Acorn Biolabs Inc.
Participants (registry)
26
Start
October 2025
Primary completion
November 2026
Study completion
November 2026
Last registry update
November 2026
Countries
United States

Conditions studied: Androgenic Alopecia, Alopecia, Baldness

Interventions: Autologous Hair Follicle-Derived Secretome, aHFS, Placebo Control

Full record on ClinicalTrials.gov ↗

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.